John Kenneth Jenkins - Net Worth and Insider Trading
John Kenneth Jenkins Net Worth
The estimated net worth of John Kenneth Jenkins is at least $592 dollars as of 2024-11-13. John Kenneth Jenkins is the Director of Corbus Pharmaceuticals Holdings Inc and owns about 33 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $592. Details can be seen in John Kenneth Jenkins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Kenneth Jenkins has not made any transactions after 2019-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Kenneth Jenkins
John Kenneth Jenkins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Kenneth Jenkins owns 2 companies in total, including Provention Bio Inc (PRVB) , and Corbus Pharmaceuticals Holdings Inc (CRBP) .
Click here to see the complete history of John Kenneth Jenkins’s form 4 insider trades.
Insider Ownership Summary of John Kenneth Jenkins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRVB | Provention Bio Inc | 2020-08-10 | director |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2019-03-15 | director |
John Kenneth Jenkins Latest Holdings Summary
John Kenneth Jenkins currently owns a total of 1 stock. John Kenneth Jenkins owns 33 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of March 15, 2019, with a value of $592.
Latest Holdings of John Kenneth Jenkins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2019-03-15 | 33 | 17.94 | 592 |
Holding Weightings of John Kenneth Jenkins
John Kenneth Jenkins Form 4 Trading Tracker
According to the SEC Form 4 filings, John Kenneth Jenkins has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 33 shares on March 15, 2019, which cost John Kenneth Jenkins around $6,980.
Insider Trading History of John Kenneth Jenkins
- 1
John Kenneth Jenkins Trading Performance
GuruFocus tracks the stock performance after each of John Kenneth Jenkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Kenneth Jenkins is 2.24%. GuruFocus also compares John Kenneth Jenkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Kenneth Jenkins within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Kenneth Jenkins's insider trading performs compared to the benchmark.
Performance of John Kenneth Jenkins
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.87 | | | | | |
| Relative Return to S&P 500(%) | 3.93 | | | | | |
John Kenneth Jenkins Ownership Network
Ownership Network List of John Kenneth Jenkins
Ownership Network Relation of John Kenneth Jenkins
John Kenneth Jenkins Owned Company Details
What does Provention Bio Inc do?
Who are the key executives at Provention Bio Inc?
John Kenneth Jenkins is the director of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & Chief Scientific Officer Francisco Leon , and director & 10 percent owner & President and CEO Ashleigh Palmer .
Provention Bio Inc (PRVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc (PRVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provention Bio Inc (PRVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Provention Bio Inc (PRVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Provention Bio Inc Insider Transactions
John Kenneth Jenkins Mailing Address
Above is the net worth, insider trading, and ownership report for John Kenneth Jenkins. You might contact John Kenneth Jenkins via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood Ma 02062.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
